Graduate School of Biomedical Sciences

New Scientific Evidence Emerges on How Individuals Transition From Recreational to Compulsive Use of Drugs

Retrieved on: 
Tuesday, March 7, 2023

Specifically, the nucleus accumbens is a region of the brain's reward circuitry that integrates midbrain inputs of dopamine -- a neurotransmitter that affects many aspects of behavior, including how we experience pleasure – to shape reward- and motivation-related behaviors. Within this construct, researchers in the Nash Family Department of Neuroscience and the Friedman Brain Institute at Icahn Mount Sinai learned that RXRα positively correlated with addiction-relevant behavioral features in laboratory rodents -- a finding that makes the molecule a strong mechanistic candidate to link individual vulnerability to cocaine addiction. Fundamental to the study was RNA sequencing on six regions of the rodent's brain reward circuitry after cocaine self-administration, withdrawal, and relapse in mice.

Key Points: 
  • Fundamental to the study was RNA sequencing on six regions of the rodent's brain reward circuitry after cocaine self-administration, withdrawal, and relapse in mice.
  • The discovery not only paves the way for future research on the novel signaling pathway, but on preventive strategies for drug addiction targeting RXRα.
  • The Mount Sinai team showed that inhibition of the molecule using a systemically administered RXRα antagonist reduced cocaine-induced associative learning with tolerable side effects.
  • Scientists were particularly intrigued and encouraged by the fact that a single molecule could have such a profound effect on modulating complex behaviors related to drug addiction.

LECOM Opens New School of Podiatric Medicine

Retrieved on: 
Monday, November 28, 2022

ERIE, Pa., Nov. 28, 2022 /PRNewswire/ -- The Lake Erie College of Osteopathic Medicine (LECOM) announced it will open a new School of Podiatric Medicine (SPM). The LECOM-SPM Erie (PA) received approval from the accreditation agency, the Council on Podiatric Medical Education, to begin accepting students for the fall semester of 2023. The LECOM-SPM is the eleventh podiatric medical school in the United States. The four-year program will be located at LECOM's main campus in Erie, Pennsylvania and will offer a unique curricular collaboration with LECOM's College of Osteopathic Medicine.

Key Points: 
  • New school is the 11th podiatric medical school in the U.S. First class will begin in 2023
    ERIE, Pa., Nov. 28, 2022 /PRNewswire/ -- The Lake Erie College of Osteopathic Medicine (LECOM) announced it will open a new School of Podiatric Medicine (SPM).
  • The LECOM School of Podiatric Medicine is the eleventh podiatric medical school in the United States.
  • Dr. Lee earned his degree in podiatric medicine from Des Moines University College of Podiatric Medicine and Surgery.
  • Enrollment in the College of Osteopathic Medicine, School of Pharmacy, School of Dental Medicine, School of Podiatric Medicine, School of Health Services Administration and Graduate School of Biomedical Sciences has surpassed 4,400 students at campuses in Erie and Greensburg, Pa., Bradenton, Fla., and Elmira,
    N.Y. LECOM consistently graduates more primary care physicians than any other U.S. medical college while maintaining one of the lowest tuitions of any private medical school in the country.

Dr. Owhofasa Agbedia Honored With The 2022 ASH-CIBMTR-ASTCT Career Development Award

Retrieved on: 
Tuesday, August 2, 2022

The Center for International Blood and Marrow Transplantation (CIBMTR), is delighted to announce that Owhofasa Agbedia, MD, MPH, has been selected to receive the ASH-CIBMTR-ASTCT Career Development Award.

Key Points: 
  • The Center for International Blood and Marrow Transplantation (CIBMTR), is delighted to announce that Owhofasa Agbedia, MD, MPH, has been selected to receive the ASH-CIBMTR-ASTCT Career Development Award.
  • The award is part of a program to increase racial and ethnic diversity in the next generation of medical professionals.
  • We believe that diversity, equity, and inclusion in our field are essential to innovation and eliminating health care disparities.
  • Along with our partner organizations, the CIBMTR is committed to supporting the career development of our next generation, particularly those with diverse backgrounds.

Dr. Owhofasa Agbedia to Receive the 2021 ASH-CIBMTR-ASTCT Career Development Award

Retrieved on: 
Wednesday, June 22, 2022

This new award is a part of the ASH Minority Hematology Fellow Award (MHFA) program, which supports early-career researchers from minority groups historically underrepresented in medicine.

Key Points: 
  • This new award is a part of the ASH Minority Hematology Fellow Award (MHFA) program, which supports early-career researchers from minority groups historically underrepresented in medicine.
  • This new partnership award is exclusively for fellows pursuing careers in hematopoietic stem cell transplantation and cellular therapy.
  • Additionally, as part of this award, Dr. Agbedia will receive opportunities from ASTCT and CIBMTR.
  • The Career Development Award is also part of ASTCT's award expansion, which includes a New Investigator Award for Underrepresented Minorities and additional Travel Grants for the Tandem Meetings: Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR.

Houston Surgeon to Participate in a National Hernia Patient-Centered Satisfaction and Outcomes Initiative

Retrieved on: 
Tuesday, February 8, 2022

Dr. Buckminster Farrow became the first Houston-area surgeon to implant SURGIMESH, a proprietary, non-woven alternative to traditional hernia mesh, in a national initiative to improve outcomes and lower costs associated with hernia surgery.

Key Points: 
  • Dr. Buckminster Farrow became the first Houston-area surgeon to implant SURGIMESH, a proprietary, non-woven alternative to traditional hernia mesh, in a national initiative to improve outcomes and lower costs associated with hernia surgery.
  • The outcomes initiative, through a partnership with CQInsights, is a first-of-kind endeavor in the hernia industry that applies principles of systems science to track patient outcomes and provide surgeons with real-world data to guide clinical practice.
  • Dr. Farrow is definitely a surgeon who will make a positive impact in the evolution of hernia surgery.
  • We are extremely enthusiastic that he has chosen to partner with the SURGIMESH team on this national initiative.